nalmefene has been researched along with salvinorin a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azar, MR; Cashman, JR; Ghirmai, S | 1 |
| Butelman, ER; Kreek, MJ; Mandau, M; Prisinzano, TE; Tidgewell, K; Yuferov, V | 1 |
2 other study(ies) available for nalmefene and salvinorin a
| Article | Year |
|---|---|
Synthesis and pharmacological evaluation of 6-naltrexamine analogs for alcohol cessation.
Topics: Alcohol Deterrents; Alcoholism; Animals; Humans; Liver; Male; Mice; Naltrexone; Nociceptin Receptor; Protein Binding; Rats; Rats, Wistar; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship | 2009 |
Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high kappa-receptor homology to humans.
Topics: Amino Acid Sequence; Animals; Benzeneacetamides; Biomarkers; Cloning, Molecular; Diterpenes; Diterpenes, Clerodane; Female; Hallucinogens; Humans; Macaca mulatta; Male; Molecular Sequence Data; Naltrexone; Prolactin; Pyrrolidines; Receptors, Opioid, kappa; Sex Characteristics | 2007 |